Trontinemab Phase 3 Clinical Trial Information

If you are interested in the Trontinemab Phase 3 Clinical Trial, email Genetech Medical Communications at genentech@medical-information.com.

You must include the study identifier in your email. It is NCT07170150.

The telephone number is 888-662-6728.

Sadly, I do not qualify for this study since I have had lecanemab infusions.

I am spending a very hot day inside completing the blog organization. All pure research blog posts will be moved to this publication. I hope to add an index and search feature to this publication.

Additionally, I depend on donations and income from my store to fund my direct and indirect Alzheimer’s treatment expenses. Every dollar helps. Thank you.